0001127602-15-027731.txt : 20150928 0001127602-15-027731.hdr.sgml : 20150928 20150928174007 ACCESSION NUMBER: 0001127602-15-027731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150924 FILED AS OF DATE: 20150928 DATE AS OF CHANGE: 20150928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 151128425 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-09-24 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Clinical R&D, CMO Common Stock 2015-09-24 4 M 0 10000 0 A 127724 D Common Stock 2015-09-28 4 S 0 5500 6.455 D 122224 D Performance stock unit 2015-09-24 4 M 0 10000 0 D Common Stock 10000 10000 D Performance stock unit 2015-09-24 4 A 0 20000 0 A Common Stock 20000 20000 D Shares were acquired upon vesting of performance stock units awarded on March 19, 2013. Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.22 to $6.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. Each performance stock unit represents a right to receive one share of ARIAD common stock. The performance stock units vest as to 50% of the award on 9/24/15 and 50% of the award on 9/24/2016. /s/Edward M. Fitzgerald, Attorney-in-Fact 2015-09-28